CDK9-IN-31 (dimaleate)

CDK9-IN-31 dimaleate (Compound Z1) is a CDK9 inhibitor that inhibits cancer cell growth. CDK9-IN-31 dimaleate has the potential to be developed as an anticancer agent[1].

Product Specifications

UNSPSC

12352005

Target

CDK

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/cdk9-in-31-dimaleate.html

Solubility

10 mM in DMSO

Smiles

O=C(O)/C=C\C(O)=O.OC[C@@H](C)N[C@@H](CC1)CC[C@H]1NC2=CC(C3=CSC(NCC4(CCOCC4)C#N)=N3)=C(Cl)C=N2.O=C(O)/C=C\C(O)=O

Molecular Formula

C32H41ClN6O10S

Molecular Weight

737.22

References & Citations

[1]Fusheng Zhou, et al. CDK9 inhibitor and preparation method and application thereof. Patent CN116496267A.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP3-06643AF405 0.1 mL

Rabbit Polyclonal DACH1 Antibody [Alexa Fluor 405]

Ask

View Details

042246-ML550 100 µL

SPNS3, CT (SPNS3, Protein spinster homolog 3) (MaxLight 550) discontinued

Ask

View Details

MP200270 200 Reactions

Arc Mouse qPCR Primer Pair (NM_018790)

Ask

View Details

APR23749N-01 50 µL

ITPKA Rabbit pAb (APR23749N)

Ask

View Details

APR23749N-02 100 µL

ITPKA Rabbit pAb (APR23749N)

Ask

View Details

APR23749N-03 200 µL

ITPKA Rabbit pAb (APR23749N)

Ask

View Details